Treatment patterns, healthcare resource utilization, and healthcare costs among patients with pulmonary arterial hypertension in a real-world US database
Several new medications for pulmonary arterial hypertension (PAH) have recently been introduced; however, current real-world data regarding US patients with PAH are limited. We conducted a retrospective administrative claims study to examine PAH treatment patterns and summarize healthcare utilizatio...
Main Authors: | Sean Studer, Michael Hull, Janis Pruett, Eleena Koep, Yuen Tsang, William Drake |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-12-01
|
Series: | Pulmonary Circulation |
Online Access: | https://doi.org/10.1177/2045894018816294 |
Similar Items
-
Retrospective Database Analysis of Treatment Patterns Among Patients with Pulmonary Arterial Hypertension
by: Sean Studer, et al.
Published: (2019-12-01) -
Baseline history of patients using selexipag for pulmonary arterial hypertension
by: Kristin B. Highland, et al.
Published: (2019-04-01) -
Comparative effectiveness of oral prostacyclin pathway drugs on hospitalization in patients with pulmonary hypertension in the United States: a retrospective database analysis
by: John W. McConnell, et al.
Published: (2020-11-01) -
Medication adherence, hospitalization, and healthcare resource utilization and costs in patients with pulmonary arterial hypertension treated with endothelin receptor antagonists or phosphodiesterase type-5 inhibitors
by: Robert P. Frantz, et al.
Published: (2020-03-01) -
Real‐world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States
by: Lia N. Pizzicato, et al.
Published: (2022-04-01)